NCT05599555View on ClinicalTrials.gov

Community-based Sero-epidemiological Study of COVID-19

CompletedOBSERVATIONAL
Enrollment

9,600

Participants

Timeline

Start Date

April 28, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

March 31, 2023

Conditions
COVID-19
Interventions
BIOLOGICAL

mRNA BNT162b2 vaccine

mRNA vaccine Comirnaty (BNT162b2 mRNA, BioNTech/Fosun-Pharma, Mainz, Germany/Shanghai, China)

BIOLOGICAL

CoronaVac vaccine

Inactivated CoronaVac vaccine (Sinovac Life Sciences, Beijing, China)

Trial Locations (1)

Unknown

The University of Hong Kong, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER